Skip to content

Clinical trials

Phase 1 Heart Failure trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 1 Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20112
20142
20171
20184
20193
20212
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
GlaxoSmithKline3
Imperial College London2
Bial - Portela C S.A.1
Bristol-Myers Squibb1
Cardior Pharmaceuticals GmbH1
Cytokinetics1
ModernaTX, Inc.1
Novo Nordisk A/S1
Papworth Hospital NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure20
Pulmonary Edema2
Cardiovascular Diseases1
Pulmonary Arterial Hypertension1
Pulmonary Disease, Chronic Obstructive1
Respiratory Insufficiency1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.